Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRV Acrivon Therapeutics, Inc.

盘前交易 05-17 07:17:33 EDT

8.56

-0.09

-1.04%

最高8.81	最低8.45	成交量4.17万
今开8.53	昨收8.65	日振幅4.16%
总市值2.64亿	流通市值1.04亿	总股本3,088万
成交额35.83万	换手率0.34%	流通股本1,216万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRV","market":"US","secType":"STK","nameCN":"Acrivon Therapeutics, Inc.","latestPrice":8.56,"timestamp":1715889600000,"preClose":8.65,"halted":0,"volume":41682,"delay":0,"floatShares":12160314,"shares":30876932,"eps":-2.882258,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.09,"latestTime":"05-17 07:17:33 EDT","open":8.53,"high":8.81,"low":8.45,"amount":358313.435838,"amplitude":0.041618,"askPrice":8.85,"askSize":29,"bidPrice":8.05,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.882258,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715952600000},"adr":0,"listingDate":1668488400000,"adjPreClose":8.56,"postHourTrading":{"tag":"盘后","latestPrice":8.56,"preClose":8.56,"latestTime":"16:02 EDT","volume":1422,"amount":12171.97,"timestamp":1715889746434},"volumeRatio":0.4079998595662957},"requestUrl":"/m/hq/s/ACRV/","defaultTab":"news","newsList":[{"id":"2434201862","title":"Acrivon Therapeutics, Inc.盘中异动 下午盘股价大涨5.53%报8.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434201862","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434201862?lang=zh_cn&edition=full","pubTime":"2024-05-11 01:46","pubTimestamp":1715363169,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日01时46分，Acrivon Therapeutics, Inc.股票出现异动，股价快速拉升5.53%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051101460987e872c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051101460987e872c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433479785","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433479785","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433479785?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:44","pubTimestamp":1715003094,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时44分，Acrivon Therapeutics, Inc.股票出现异动，股价急速跳水6.05%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621445579260d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621445579260d81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430285720","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大跌5.68%报8.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285720","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430285720?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:32","pubTimestamp":1714051943,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时32分，Acrivon Therapeutics, Inc.股票出现异动，股价急速下挫5.68%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213223861e9063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213223861e9063&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426268164","title":"Acrivon Therapeutics, Inc.盘中异动 早盘大幅下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426268164","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426268164?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:42","pubTimestamp":1712842966,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时42分，Acrivon Therapeutics, Inc.股票出现波动，股价快速跳水5.29%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112142467a522cc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112142467a522cc5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426940375","title":"Acrivon Therapeutics, Inc.盘中异动 下午盘股价大跌7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426940375","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426940375?lang=zh_cn&edition=full","pubTime":"2024-04-09 02:55","pubTimestamp":1712602510,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日02时55分，Acrivon Therapeutics, Inc.股票出现异动，股价快速下挫7.10%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409025511861e3fae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409025511861e3fae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422611784","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.92%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422611784","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422611784?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:22","pubTimestamp":1711462957,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时22分，Acrivon Therapeutics, Inc.股票出现异动，股价大幅上涨5.92%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326222237861e143a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326222237861e143a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420723652","title":"Acrivon Therapeutics, Inc.股价拉升12.61% 市值涨111.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420723652","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420723652?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:54","pubTimestamp":1710942877,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时54分，Acrivon Therapeutics, Inc.股票出现波动，股价急速上涨12.61%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202154387a4df9f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202154387a4df9f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419657856","title":"Acrivon Therapeutics, Inc.盘中异动 快速拉升5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419657856","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419657856?lang=zh_cn&edition=full","pubTime":"2024-03-14 03:58","pubTimestamp":1710359935,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日03时58分，Acrivon Therapeutics, Inc.股票出现波动，股价急速上涨5.81%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314035856861ddeaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314035856861ddeaa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417057797","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨7.21%报5.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417057797","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417057797?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:33","pubTimestamp":1709908388,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时33分，Acrivon Therapeutics, Inc.股票出现波动，股价大幅上涨7.21%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082233088765cb9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082233088765cb9e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417482762","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大涨5.05%报4.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417482762","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417482762?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:32","pubTimestamp":1709821926,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时32分，Acrivon Therapeutics, Inc.股票出现波动，股价急速上涨5.05%。截至发稿，该股报4.99美元/股，成交量1936股，换手率0.01%，振幅0.00%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.41%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072232077918467b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072232077918467b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413424816","title":"Acrivon Therapeutics Inc盘中异动 股价大涨5.88%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413424816","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413424816?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:00","pubTimestamp":1708527606,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日23时00分，Acrivon Therapeutics Inc股票出现异动，股价大幅上涨5.88%。截至发稿，该股报3.98美元/股，成交量1365股，换手率0.01%，振幅0.00%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.07%。Acrivon Therapeutics Inc公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212300077913246d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212300077913246d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407739147","title":"Acrivon Therapeutics Inc盘中异动 股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407739147","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407739147?lang=zh_cn&edition=full","pubTime":"2024-01-31 02:48","pubTimestamp":1706640498,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日02时48分，Acrivon Therapeutics Inc股票出现异动，股价大幅下跌5.71%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Neximmune Inc、Pepgen Inc、Gri Bio Inc涨幅较大，Neximmune Inc、Panbela Therapeutics Inc、Gri Bio Inc较为活跃，换手率分别为1545.28%、287.11%、252.34%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Gri Bio Inc，振幅分别为800.00%、218.65%、89.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013102481987e69e91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013102481987e69e91&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406479574","title":"Acrivon Therapeutics Inc盘中异动 股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406479574","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406479574?lang=zh_cn&edition=full","pubTime":"2024-01-25 04:12","pubTimestamp":1706127138,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日04时12分，Acrivon Therapeutics Inc股票出现异动，股价大幅下挫5.88%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.77%。Acrivon Therapeutics Inc公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401250412187a3e12a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401250412187a3e12a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402212479","title":"Acrivon Therapeutics Inc盘中异动 快速跳水5.18%报4.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402212479","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402212479?lang=zh_cn&edition=full","pubTime":"2024-01-11 22:57","pubTimestamp":1704985051,"startTime":"0","endTime":"0","summary":"北京时间2024年01月11日22时57分，Acrivon Therapeutics Inc股票出现波动，股价大幅跳水5.18%。截至发稿，该股报4.39美元/股，成交量4056股，换手率0.02%，振幅4.75%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.20%。Acrivon Therapeutics Inc公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401112257327a3a608a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401112257327a3a608a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402913042","title":"Acrivon Therapeutics Inc盘中异动 急速上涨5.95%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402913042","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402913042?lang=zh_cn&edition=full","pubTime":"2024-01-09 23:54","pubTimestamp":1704815657,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日23时54分，Acrivon Therapeutics Inc股票出现波动，股价快速拉升5.95%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.66%。Acrivon Therapeutics Inc公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401092354187a39a8df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401092354187a39a8df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400691188","title":"Acrivon Therapeutics Inc盘中异动 急速拉升5.28%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2400691188","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400691188?lang=zh_cn&edition=full","pubTime":"2024-01-02 23:30","pubTimestamp":1704209404,"startTime":"0","endTime":"0","summary":"北京时间2024年01月02日23时30分，Acrivon Therapeutics Inc股票出现波动，股价快速拉升5.28%。截至发稿，该股报5.18美元/股，成交量1.2275万股，换手率0.06%，振幅6.40%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.10%。Acrivon Therapeutics Inc公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401022330047905a35e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401022330047905a35e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393419408","title":"Acrivon Therapeutics Inc盘中异动 股价大涨6.57%报5.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393419408","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393419408?lang=zh_cn&edition=full","pubTime":"2023-12-23 01:23","pubTimestamp":1703265821,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日01时23分，Acrivon Therapeutics Inc股票出现异动，股价大幅拉升6.57%。Acrivon Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.59%。Acrivon Therapeutics Inc公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223012341861c680f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223012341861c680f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acrivon.com","stockEarnings":[{"period":"1week","weight":0.0516},{"period":"1month","weight":-0.0961},{"period":"3month","weight":1.1726},{"period":"6month","weight":1.2005},{"period":"1year","weight":-0.3659},{"period":"ytd","weight":0.7398}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acrivon Therapeutics, Inc.于2018年3月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，开发精确的肿瘤药物，该公司利用其专有的基于蛋白质组学的患者应答者识别平台，将其与肿瘤预测对每种特定药物敏感的患者相匹配。该公司通过使用其专有的精密药物平台AP3来开发其候选肿瘤药物管道。（该公司的AP3平台能够创建药物专用专有OncoSignature伴随诊断，用于识别最有可能从该公司候选药物中获益的患者，该公司称之为患者应答者）。","exchange":"NASDAQ","name":"Acrivon Therapeutics, Inc.","nameEN":"Acrivon Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acrivon Therapeutics, Inc.,ACRV,Acrivon Therapeutics, Inc.股票,Acrivon Therapeutics, Inc.股票老虎,Acrivon Therapeutics, Inc.股票老虎国际,Acrivon Therapeutics, Inc.行情,Acrivon Therapeutics, Inc.股票行情,Acrivon Therapeutics, Inc.股价,Acrivon Therapeutics, Inc.股市,Acrivon Therapeutics, Inc.股票价格,Acrivon Therapeutics, Inc.股票交易,Acrivon Therapeutics, Inc.股票购买,Acrivon Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}